source
- Definium Therapeutics reports positive Phase 3 results for oral LSD anxiety drug DT120Definium Therapeutics announced Monday that its experimental oral LSD formulation, DT120, achieved positive outcomes in a Phase 3 trial targeting an anxiety disorder. The trial, the company's thir…
- Novo Nordisk shortens its name in brand and culture rebootIn a brand reboot, Novo Nordisk is shortening its name and adopting a new culture strategy after a series of setbacks this year. From Monday on, the Danish drugmaker will commonly be known as "Novo…Endpoints · 24m ago↗ source